Gil Blum
Stock Analyst at Needham
(2.01)
# 2,884
Out of 4,847 analysts
385
Total ratings
33.97%
Success rate
-7.08%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Gil Blum
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TSHA Taysha Gene Therapies | Reiterates: Buy | $6 → $8 | $2.90 | +176.34% | 27 | Jun 2, 2025 | |
| CRSP CRISPR Therapeutics AG | Reiterates: Buy | $81 | $37.86 | +113.95% | 22 | May 20, 2025 | |
| CELC Celcuity | Reiterates: Buy | $29 | $11.91 | +143.49% | 16 | May 15, 2025 | |
| ARTV Artiva Biotherapeutics | Maintains: Buy | $23 → $18 | $1.96 | +818.37% | 6 | May 15, 2025 | |
| ABSI Absci | Reiterates: Buy | $9 | $2.77 | +224.91% | 4 | May 14, 2025 | |
| AUTL Autolus Therapeutics | Reiterates: Buy | $10 | $2.11 | +375.06% | 27 | Apr 10, 2025 | |
| ACLX Arcellx | Reiterates: Buy | $105 | $64.71 | +62.26% | 23 | Dec 10, 2024 | |
| RCKT Rocket Pharmaceuticals | Downgrades: Hold | $42 | $3.01 | +1,297.67% | 21 | May 27, 2025 | |
| NKTX Nkarta | Maintains: Buy | $11 → $10 | $1.78 | +461.80% | 17 | May 15, 2025 | |
| FATE Fate Therapeutics | Reiterates: Hold | n/a | $1.35 | - | 7 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.65 | +164.15% | 18 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $40 | $10.04 | +298.41% | 15 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $0.38 | +1,996.99% | 17 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $183 → $125 | $38.75 | +222.58% | 31 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $8 | $4.36 | +83.49% | 23 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $27 | $12.39 | +117.92% | 24 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $71 | $38.75 | +83.23% | 14 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.63 | +453.85% | 7 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $1.93 | +107.25% | 13 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $1.02 | - | 16 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.57 | +219.49% | 22 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $6.29 | - | 6 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $0.48 | +734.55% | 9 | Aug 2, 2024 |
Taysha Gene Therapies
Jun 2, 2025
Reiterates: Buy
Price Target: $6 → $8
Current: $2.90
Upside: +176.34%
CRISPR Therapeutics AG
May 20, 2025
Reiterates: Buy
Price Target: $81
Current: $37.86
Upside: +113.95%
Celcuity
May 15, 2025
Reiterates: Buy
Price Target: $29
Current: $11.91
Upside: +143.49%
Artiva Biotherapeutics
May 15, 2025
Maintains: Buy
Price Target: $23 → $18
Current: $1.96
Upside: +818.37%
Absci
May 14, 2025
Reiterates: Buy
Price Target: $9
Current: $2.77
Upside: +224.91%
Autolus Therapeutics
Apr 10, 2025
Reiterates: Buy
Price Target: $10
Current: $2.11
Upside: +375.06%
Arcellx
Dec 10, 2024
Reiterates: Buy
Price Target: $105
Current: $64.71
Upside: +62.26%
Rocket Pharmaceuticals
May 27, 2025
Downgrades: Hold
Price Target: $42
Current: $3.01
Upside: +1,297.67%
Nkarta
May 15, 2025
Maintains: Buy
Price Target: $11 → $10
Current: $1.78
Upside: +461.80%
Fate Therapeutics
May 14, 2025
Reiterates: Hold
Price Target: n/a
Current: $1.35
Upside: -
May 13, 2025
Reiterates: Buy
Price Target: $7
Current: $2.65
Upside: +164.15%
May 8, 2025
Maintains: Buy
Price Target: $41 → $40
Current: $10.04
Upside: +298.41%
May 8, 2025
Reiterates: Buy
Price Target: $8
Current: $0.38
Upside: +1,996.99%
May 7, 2025
Maintains: Buy
Price Target: $183 → $125
Current: $38.75
Upside: +222.58%
May 6, 2025
Maintains: Buy
Price Target: $11 → $8
Current: $4.36
Upside: +83.49%
Apr 29, 2025
Reiterates: Buy
Price Target: $27
Current: $12.39
Upside: +117.92%
Apr 10, 2025
Reiterates: Buy
Price Target: $71
Current: $38.75
Upside: +83.23%
Apr 8, 2025
Reiterates: Buy
Price Target: $9
Current: $1.63
Upside: +453.85%
Apr 4, 2025
Reiterates: Buy
Price Target: $4
Current: $1.93
Upside: +107.25%
Mar 27, 2025
Reiterates: Hold
Price Target: n/a
Current: $1.02
Upside: -
Mar 12, 2025
Reiterates: Buy
Price Target: $5
Current: $1.57
Upside: +219.49%
Feb 20, 2025
Reiterates: Hold
Price Target: n/a
Current: $6.29
Upside: -
Aug 2, 2024
Reiterates: Buy
Price Target: $4
Current: $0.48
Upside: +734.55%